Makiko Kuwagata
| Faculty of Health Care and Medical Sports,Department of Medical Sports,Animal Medical Course | Professor |
Last Updated :2025/10/07
■Research activity information
Paper
- A 90-day repeated oral dose toxicity study of p-cymene in rats
Makiko Kuwagata; Yuko Doi; Hirokatsu Saito; Mariko Tsurumoto; Toshime Igarashi; Takuya Nishimura; Yuhji Taquahashi; Yoko Hirabayashi; Satoshi Kitajima
Fundamental Toxicological Sciences, 2024 - Extracellular vesicle small RNAs secreted from mouse amniotic fluid induced by repeated oral administration of VPA to pregnant mice
Ryuichi Ono; Makiko Kuwagata; Mie Naruse; Akihito Watanabe; Masao Takano; Takuro Hasegawa; Hiromasa Takashima; Yusuke Yoshioka; Takahiro Ochiya; Yoko Hirabayashi; Satoshi Kitajima
Fundamental Toxicological Sciences, 2024 - フードテックを応用した細胞培養食品を含む「新規食品」の安全性確保に関する諸外国の制度比較と最近の動向
Jun. 2023 - A 90-day repeated oral dose toxicity study of 2-Butylbenzo[d]isothiazol-3(2H)-one in rats
Makiko Kuwagata; Masaru Tsuboi; Toshime Igarashi; Mariko Tsurumoto; Takuya Nishimura; Yuhji Taquahashi; Satoshi Kitajima
Fundamental Toxicological Sciences, 2023 - A 90-day dose toxicity study of 2-(2H-benzotriazol-2-yl)-6-dodecyl-4-methylphenol in rats
Makiko Kuwagata; Masaru Tsuboi; Toshime Igarashi; Mariko Tsurumoto; Takuya Nishimura; Yuhji Taquahashi; Satoshi Kitajima
Fundamental Toxicological Sciences, 2023 - Development of an inhalation exposure system of a pressurized metered-dose inhaler (pMDI) formulation for small experimental animals
Yuhji Taquahashi; Hirokatsu Saito; Makiko Kuwagata; Satoshi Kitajima
Fundamental Toxicological Sciences, Oct. 2021, [Reviewed] - Visualizing the spatial localization of ciclesonide and its metabolites in rat lungs after inhalation of 1-μm aerosol of ciclesonide by desorption electrospray ionization-time of flight mass spectrometry imaging.
Eiichi Yamamoto; Yuhji Taquahashi; Makiko Kuwagata; Hirokatsu Saito; Kohei Matsushita; Takeshi Toyoda; Futoshi Sato; Satoshi Kitajima; Kumiko Ogawa; Ken-Ichi Izutsu; Yoshiro Saito; Yoko Hirabayashi; Yasuo Iimura; Masamitsu Honma; Haruhiro Okuda; Yukihiro Goda
International journal of pharmaceutics, 15 Feb. 2021, [Reviewed]
Inhaled ciclesonide (CIC), a corticosteroid used to treat asthma that is also being investigated for the treatment of corona virus disease 2019, hydrolyzes to desisobutyryl-ciclesonide (des-CIC) followed by reversible esterification when exposed to fatty acids in lungs. While previous studies have described the distribution and metabolism of the compounds after inhalation, spatial localization in the lungs remains unclear. We visualized two-dimensional spatial localization of CIC and its metabolites in rat lungs after administration of a single dose of a CIC aerosol (with the mass median aerodynamic diameter of 0.918-1.168 μm) using desorption electrospray ionization-time of flight mass spectrometry imaging (DESI-MSI). In the analysis, CIC, des-CIC, and des-CIC-oleate were imaged in frozen lung sections at high spatial and mass resolutions in negative-ion mode. MSI revealed the coexistence of CIC, des-CIC, and des-CIC-oleate on the airway epithelium, and the distribution of des-CIC and des-CIC-oleate in peripheral lung regions. In addition, a part of CIC independently localized on the airway epithelium. These results suggest that distribution of CIC and its metabolites in lungs is related to both the intended delivery of aerosols to pulmonary alveoli and peripheral regions, and the potential deposition of CIC particles on the airway epithelium. - Pharmacokinetics of primary metabolites 5-hydroxythalidomide and 5′-hydroxythalidomide formed after oral administration of thalidomide in the rabbit, a thalidomide-sensitive species
Makiko Kuwagata; Takuro Hasegawa; Hiromasa Takashima; Makiko Shimizu; Satoshi Kitajima; Hiroshi Yamazaki
The Journal of Toxicological Sciences, 2021, [Reviewed] - Diverse unintended on-target mutations induced by zygote genome-editing using CRISPR/Cas9 system
Toshime Igarashi; Yukuto Yasuhiko; Ryuichi Ono; Erika Tachihara; Miki Uchiyama; Atsuya Takagi; Yu Takahashi; Makiko Kuwagata; Satoshi Kitajima
Fundamental Toxicological Sciences, 2021, [Reviewed] - 5-Fluorocytosine induces fetal skeletal malformations in rats by altering expression of Homeobox genes
Takayuki Kumamoto; Mika Senuma; Mai Todoroki; Fumiaki Kumagai; Hajime Imai; Reiko Suzuki; Tetsuo Ogawa; Makiko Kuwagata
Fundamental Toxicological Sciences, 2020, [Reviewed] - Hypothalamic Monoaminergic Pathology in a Neurodevelopmental Rat Model Showing Prenatal 5-Bromo-2'-Deoxyuridine Treatment-Induced Hyperactivity and Hyporeproductivity.
Makiko Kuwagata; Katsumasa Muneoka; Kazuho Honda; Akira Miyazaki
Neuropsychobiology, 2020, [Reviewed]
OBJECTIVE: Prenatal treatment of rats with 5-bromo-2'-deoxyuridine (BrdU) is a neurodevelopmental model showing hyperactivity and impaired sexual activity. Human neurodevelopmental disorders, such as autism, exhibit sex-related pathology, but sex-related neurodevelopment has not been fully investigated in this model. We conducted this study to facilitate the understanding of the pathophysiology of neurodevelopmental disorders. METHODS: Pregnant rats received 50 mg/kg BrdU on gestational days 9-15. The tissue content of dopamine (DA), serotonin (5-HT), and their metabolites dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindoleacetic acid were measured in male and female offspring at 3 weeks (juveniles) and 10 weeks (adults) of age. RESULTS: Prenatally BrdU-treated rats had reduced DA metabolism or DA content in the hypothalamus from the juvenile through the adult period without sex differences, but sex-specific striatal DA abnormalities emerged after maturation. A reduction in 5-HT metabolism was measured in the hypothalamus without sex differences throughout development. Developmental alterations in the striatal 5-HT states were sex-dependent. Temporal changes in DA or 5-HT metabolism were found in the frontal cortex and midbrain. CONCLUSION: The sex-specific influence of a genotoxic factor on the development of the DA and 5-HT systems was clarified in the hypothalamus and striatum. The results suggest that the observed sex dependence and region specificity are related to the pathology of social dysfunction in neurodevelopmental disorders. - Novel hepatotoxicity biomarkers of extracellular vesicle (EV)-associated miRNAs induced by CCl4.
Ryuichi Ono; Yusuke Yoshioka; Yusuke Furukawa; Mie Naruse; Makiko Kuwagata; Takahiro Ochiya; Satoshi Kitajima; Yoko Hirabayashi
Toxicology reports, 2020, [Reviewed]
Recent findings have revealed that extracellular vesicles (EVs) are secreted from cells and circulate in the blood. EVs are classified as exosomes (40-100 nm), microvesicles (50-1,000 nm) or apoptotic bodies (500-2,000 nm). EVs contain mRNAs, microRNAs, and DNAs and have the ability to transfer them from cell to cell. Recently, especially in humans, the diagnostic accuracy of tumor cell type-specific EV-associated miRNAs as biomarkers has been found to be more than 90 %. In addition, microRNAs contained in EVs in blood are being identified as specific biomarkers of chemical-induced inflammation and organ damage. Therefore, microRNAs contained in the EVs released into the blood from tissues and organs in response to adverse events such as exposure to chemical substances and drugs are expected to be useful as novel biomarkers for toxicity assessment. In this study, C57BL/6 J male mice orally dosed with carbon tetrachloride (CCl4) were used as a hepatotoxicity animal model. Here, we report that not only the known hepatotoxicity biomarkers miR-122 and miR-192 but also 42 novel EV-associated biomarkers were upregulated in mice dosed with CCl4. Some of these novel biomarkers may be expected to be able to use for better understanding the mechanism of toxicity. These results suggest that our newly developed protocol using EV-associated miRNAs as a biomarker would accelerate the rapid evaluation of toxicity caused by chemical substances and/or drugs. - Induction of a thoracolumbar supernumerary rib in rat developmental toxicity studies: A short discussion on the critical window.
Makiko Kuwagata; Mika Senuma; Mai Todoroki; Fumiaki Kumagai; Takayuki Kumamoto; Tetsuo Ogawa
Congenital anomalies, Nov. 2019, [Reviewed]
Thoracolumbar supernumerary ribs (TSRs) are classified as less severe skeletal anomalies in rat developmental toxicity studies, although their incidence is relatively high in rodent studies. To investigate the characteristics of the critical window for chemically-induced TSR, in this study, rats were administered 5-fluorocytocine (5-FC) or sodium salicylate (SAL) at one of three time periods on gestational day (GD) 9, early morning (7:00 am), midday (12:00 pm to 1:00 pm), or late afternoon (4:00 pm or 7:00 pm). The incidence of TSR and other anomalies were assessed in GD20 fetuses. A single treatment with both chemicals on GD9-induced TSR, with the incidence highest when administered at 7:00 Am, decreasing gradually when administered later. This trajectory was clearer in rats treated with 5-FC than with SAL. The critical period of TSR induction is shorter in rats administered 5-FC than SAL. The characteristics of the critical window may cause variability in the incidence of TSR observed in developmental toxicity studies. - Update of the DevTox data database for harmonized risk assessment and alternative methodologies in developmental toxicology: Report of the 9th Berlin Workshop on Developmental Toxicity.
Roland Solecki; Martina Rauch; Andrea Gall; Jochen Buschmann; Rupert Kellner; Olena Kucheryavenko; Anne Schmitt; Nathalie Delrue; Weihua Li; Jingying Hu; Michio Fujiwara; Makiko Kuwagata; Alberto Mantovani; Susan L Makris; Francisco Paumgartten; Gilbert Schönfelder; Steffen Schneider; Silvia Vogl; Nicole Kleinstreuer; Marlon Schneider; Frank Schulze; Ellen Fritsche; Ruth Clark; Kohei Shiota; Ibrahim Chahoud
Reproductive toxicology (Elmsford, N.Y.), Oct. 2019, [Reviewed]
Representatives of applied science (e.g. governmental organizations, academia, and industry) met to discuss the progress towards a harmonized human health risk assessment in developmental toxicology of plant protection products, biocidal products, and other environmental chemicals at the 9th Berlin Workshop on Developmental Toxicity held in September 2018. Within the focus of the scientific discussion were the future of in-vitro methods for developmental and reproductive toxicology, the potential relevance of alternative species in testing of developmental effects, and risk and hazard assessment of developmental and endocrine effects. Furthermore, the need for a harmonized terminology for classification of anomalies in laboratory animals in developmental toxicity studies aiming for human health risk assessment was determined. Here, the DevTox database was identified as an extremely valuable tool. Overall, the participants agreed that still one of the biggest challenges for testing developmental toxicity in the 21st century is the development of animal-free test strategies and alternatives to animal testing that could provide human-relevant information in a rapid, efficient, and mechanistically informative manner. - Historical control data on developmental toxicity studies in rats.
Makiko Kuwagata; Yuko Sakai; Sho Tanaka; Hiromasa Takashima; Ryuichi Katagiri; Toshiki Matsuoka; Kenichi Noritake; Mika Senuma; Tatsuya Shimizu; Hitoshi Hojo; Kanata Ibi; Satoshi Kudo; Takafumi Oota; Masayuki Ube; Yoji Miwa; Shimpei Kajita; Tohru Uesugi; Kaoru Yabe; Taishi Tateishi; Nao Nakano; Terumasa Taniguchi; Akihito Yamashita; Takayuki Hirano; Yuka Kirihata; Yumi Sakai; Shino Nishizawa; Michio Fujiwara; Hiroshi Mineshima; Masao Horimoto; Makoto Ema
Congenital anomalies, Jul. 2019, [Reviewed]
Historical control data from prenatal developmental toxicity studies in rats have been used to evaluate whether toxicology outcomes were induced by exposure to a chemical or were within the range of spontaneous variation. These data are also important for monitoring animal characteristics. As a follow-up to historical control data from 1998 to 2010, this study analyzed control data from prenatal developmental studies performed in rats from 2011 to 2015. Data were collected from studies performed by 24 Japanese laboratories, including 15 pharmaceutical and chemical companies and nine contract research organizations, in Sprague-Dawley and two-sub-strains of Wistar Hannover rats. The data included maternal reproductive findings at terminal cesarean section and fetal findings, including incidences of spontaneous external, visceral, and skeletal anomalies. No noticeable differences in maternal reproductive data were observed among laboratories. The inter-laboratory variations in the incidences of fetal anomalies seemed to be due to differences in the selection of observation parameters, observation criteria, and classification of the findings, as well as to differences in terminology of fetal alterations. These historical control data may be helpful for adequate interpretation of experimental results and for evaluating the reproductive and developmental toxicities of various chemicals. - Stress-reactive rats (high-avoidance female rats) have a shorter lifespan than stress-nonreactive rats (low-avoidance female rats).
Ryo Ohta; Fumiaki Kumagai; Hideki Marumo; Kenji Usumi; Yoshiaki Saito; Makiko Kuwagata
Journal of toxicologic pathology, Apr. 2016, [Reviewed]
Although Hatano high-avoidance and low-avoidance rats (HAA and LAA, respectively) have been selectively bred for good versus poor avoidance learning, HAA rats are known to be more reactive to stress than LAA rats. In this study, HAA and LAA female rats were compared during reproductive aging by observing estrous cycles from 8 to 11 months of age. Furthermore, these rats were allowed to live out their natural lifespans, that is, until 24 months of age, in order to compare their survival and to clarify the relationship between reproductive aging and tumor development. At eight months of age, 2 of 35 HAA rats and 20 of 35 LAA rats had abnormal estrous cycles. The median lifespan of the HAA rats (673 days) was shorter than that of the LAA rats (733 days). The incidence of pituitary neoplasia was higher in the HAA rats than in the LAA rats. These results suggest that HAA female rats (i.e., stress-reactive rats) have a shorter lifespan than LAA female rats (i.e., stress-nonreactive rats) and develop pituitary neoplasia, which was one of the causal factors in their accelerated mortality. However, the onset of an age-matched abnormal cycle did not correspond with their lifespan. - Distinct effects of the serotonin-noradrenaline reuptake inhibitors milnacipran and venlafaxine on rat pineal monoamines.
Katsumasa Muneoka; Makiko Kuwagata; Tetsuo Ogawa; Seiji Shioda
Neuroreport, 17 Jun. 2015, [Reviewed]
Monoamine systems are involved in the pathology and therapeutic mechanism of depression. The pineal gland contains large amounts of serotonin as a precursor for melatonin, and its activity is controlled by noradrenergic sympathetic nerves. Pineal diurnal activity and its release of melatonin are relevant to aberrant states observed in depression. We investigated the effects on pineal monoamines of serotonin-noradrenaline reuptake inhibitors, which are widely used antidepressants. Four days of milnacipran treatment led to an increase in noradrenaline and serotonin levels, whereas 4 days of venlafaxine treatment reduced 5-hydroxyindoleacetic acid levels; both agents induced an increase in dopamine levels. Our data suggest that milnacipran increases levels of the precursor for melatonin synthesis by facilitating the noradrenergic regulation of pineal activity and that venlafaxine inhibits serotonin reuptake into noradrenergic terminals on the pineal gland. - Mother/offspring co-administration of the traditional herbal remedy yokukansan during the nursing period influences grooming and cerebellar serotonin levels in a rat model of neurodevelopmental disorders.
Katsumasa Muneoka; Makiko Kuwagata; Tetsuo Ogawa; Seiji Shioda
Cerebellum (London, England), Apr. 2015, [Reviewed]
Neurodevelopmental impairment in the serotonergic system may be involved in autism spectrum disorder. Yokukansan is a traditional herbal remedy for restlessness and agitation in children, and mother-infant co-administration (MICA) to both the child and the nursing mother is one of the recommended treatment approaches. Recent studies have revealed the neuropharmacological properties of Yokukansan (YKS), including its 5-HT1A (serotonin) receptor agonistic effects. We investigated the influence of YKS treatment on behavior in a novel environment and on brain monoamine metabolism during the nursing period in an animal model of neurodevelopmental disorders, prenatally BrdU (5-bromo-2'-deoxyuridine)-treated rats (BrdU-rats). YKS treatment did not influence locomotor activity in BrdU-rats but reduced grooming in open-field tests. YKS treatment without MICA disrupted the correlation between locomotor behaviors and rearing and altered levels of serotonin and its metabolite in the cerebellum. These effects were not observed in the group receiving YKS treatment with MICA. These data indicate a direct pharmacological effect of YKS on the development of grooming behavior and profound effects on cerebellar serotonin metabolism, which is thought to be influenced by nursing conditions. - Seeking genes responsible for developmental origins of health and disease from the fetal mouse liver following maternal food restriction.
Tetsuo Ogawa; Junko Shibato; Randeep Rakwal; Tomomi Saito; Gaku Tamura; Makiko Kuwagata; Seiji Shioda
Congenital anomalies, Nov. 2014, [Reviewed]
Low birthweight resulting from a non-optimal fetal environment is correlated epidemiologically to a higher risk of adult diseases, and which has also been demonstrated using animal models for maternal undernutrition. In this study, we subjected pregnant mice to 50% food restriction (FR), and profiled gene expression and promoter DNA methylation genome-wide using the fetal livers. The fact that effect of food restriction is opposite between before and after birth encouraged us to hunt for genes that are expressed oppositely to adult calorie restriction (CR) using the maternal livers. Among oppositely regulated genes, we identified trib1 (tribbles homolog 1). Using genetically modified mice, trib1 has been shown to have a demonstrable contribution to a risk of hypertriglyceridaemia and insulin resistance. Our data showed that the trib1 expression and its promoter DNA methylation could be affected physiologically (by maternal nutrition), and therefore might be a strong candidate gene for developmental origins of adult diseases. Furthermore, lepr (leptin receptor) gene was downregulated by maternal FR, indicating its potential role in induction of obesity and diabetes. Gene expression as well as promoter DNA methylation profiling revealed that glucocorticoid receptor target genes were regulated by maternal FR. This supports previous studies that suggest an important role of fetal glucocorticoid exposure in the mechanism of developmental origins of diseases. Our transcriptomics profiling data also suggested that maternal FR impaired development of the immune system. An inventory of candidate genes responsible for developmental origins of health and disease is presented and discussed in this study. - Prenatal sodium arsenite affects early development of serotonergic neurons in the fetal rat brain.
Mika Senuma; Chisato Mori; Tetsuo Ogawa; Makiko Kuwagata
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, Nov. 2014, [Reviewed]
Prenatal arsenite exposure has been associated with developmental disorders in children, including reduced IQ and language abnormalities. Animal experiments have also shown that exposure to arsenite during development induced developmental neurotoxicity after birth. However, the evidence is not enough, and the mechanism is poorly understood, especially on the exposure during early brain development. This study assessed effects of sodium (meta) arsenite shortly after exposure on early developing fetal rat brains. Pregnant rats were administered 50 mg/L arsenite in their drinking water or 20 mg/kg arsenite orally using a gastric tube, on gestational days (GD) 9-15. Fetal brains were examined on GD16. Pregnant rats administered 20 mg/kg arsenite showed reductions in maternal body weight gain and food consumption during treatment, but not with 50 mg/L arsenite. Arsenite did not affect fetal development, as determined by body weight, mortality and brain size. Arsenite also did not induce excessive cell death or affect neural cell division in any region of the fetal neuroepithelium. Thyrosine hydroxylase immunohistochemistry revealed no difference in the distribution of catecholaminergic neurons between fetuses of arsenite treated and control rats. However, reductions in the number of serotonin positive cells in the fetal median and dorsal raphe nuclei were observed following maternal treatment with 20mg/kg arsenite. Image analysis showed that the serotonin positive areas decreased in all fetal mid- and hind-brain areas without altering distribution patterns. Maternal stress induced by arsenite toxicity did not alter fetal development. These results suggest that arsenite-induced neurodevelopmental toxicity involves defects in the early development of the serotonin nervous system. - Tranexamic acid induces kaolin intake stimulating a pathway involving tachykinin neurokinin 1 receptors in rats.
Hitoshi Kakiuchi; Asako Kawarai-Shimamura; Makiko Kuwagata; Kensuke Orito
European journal of pharmacology, 15 Jan. 2014, [Reviewed]
Tranexamic acid suppresses post-partum haemorrhage and idiopathic menorrhagia through its anti-fibrinolytic action. Although it is clinically useful, it is associated with high risks of side effects such as emesis. Understanding the mechanisms underlying tranexamic acid-induced emesis is very important to explore appropriate anti-emetic drugs for the prevention and/or suppression of emesis. In this study, we examined the receptors involved in tranexamic acid-induced kaolin intake in rats, which reflects the drug's clinical emetogenic potential in humans. Further, we examined the brain regions activated by administration of tranexamic acid and elucidated pivotal pathways of tranexamic acid-induced kaolin intake. We examined the effects of ondansetron, a 5-hydroxytryptamine 3 receptor antagonist, domperidone, a dopamine 2 receptor antagonist, and aprepitant, a tachykinin neurokinin 1 (NK1) receptor antagonist, on tranexamic acid-induced kaolin intake in rats. Then, we determined the brain regions that showed increased numbers of c-Fos immunoreactive cells. Finally, we examined the effects of an antagonist(s) that reduced tranexamic acid-induced kaolin intake on the increase in c-Fos immunoreactive cells. Aprepitant significantly decreased tranexamic acid-induced kaolin intake. However, neither ondansetron nor domperidone decreased kaolin intake. Tranexamic acid significantly increased c-Fos immunoreactive cells by approximately 5.5-fold and 22-fold in the area postrema and nucleus of solitary tract, respectively. Aprepitant decreased the number of c-Fos immunoreactive cells in both areas. Tranexamic acid induced kaolin intake possibly via stimulation of tachykinin NK1 receptors in rats. The tachykinin NK1 receptor could be targeted to prevent and/or suppress emesis in patients receiving tranexamic acid. - Study for collecting background data on Wistar Hannover [Crl:WI(Han)] rats in general toxicity studies--comparative data to Sprague Dawley rats.
Kazuhiro Hayakawa; Yuichi Mimura; Shigehiro Tachibana; Mami Furuya; Terutaka Kodama; Toyohiko Aoki; Satoru Hosokawa; Motoko Fukui; Seiji Shibata; Masanao Yoshida; Takeshi Masuyama; Takahiro Narita; Makiko Kuwagata; Shigeru Hisada; Eiji Maki
The Journal of toxicological sciences, 2013, [Reviewed]
The purpose of the present study was to collect background data from repeated dose toxicity studies in Wistar Hannover [Crl:WI(Han)] (hereafter Wistar Han) rats with dosing periods of 4, 13 and 26 weeks from four safety research facilities of pharmaceutical companies and contract research organizations participating in the International Genetic Standardization (IGS) rat forum supported by Charles River Laboratories Japan, Inc. The data from Wistar Han rats were compared with those from Sprague Dawley Crl:CD(SD) rats. In addition, the effects of restricted feeding of SD rats were also investigated by one facility. As a result, body weights and food consumption in Wistar Han rats were lower than those of SD rats. White blood cell (WBC), neutrophil, lymphocyte, monocyte and eosinophil counts were almost half of those noted for SD rats and platelet counts were almost 20% less than those in SD rats. Minimal strain differences were noted in several biochemical parameters including aspartate aminotransferase (AST), alanine aminotransferase, total cholesterol, triglyceride and phospholipids, and in thymus, ovary and testis weights. Ophthalmologic or histopathologic examinations revealed a higher incidence of corneal opacities or corneal mineralization in Wistar Han rats. Restricted feeding of SD rats resulted in intermediate values for body weights and food consumption between the ad libitum fed SD and Wistar Han rats, and WBC and AST were lower than those in the ad libitum fed SD rats. Based on these results, some strain differences might be ascribable to reduced food consumption and associated body weight changes in Wistar Han rats. - Abnormal brain function of the rat neonate in a prenatal 5-bromo-2'-deoxyuridine (BrdU)-induced developmental disorder model.
Tetsuo Ogawa; Makiko Kuwagata; Katsumasa Muneoka; Chizu Wakai; Mika Senuma; Hiroko Kubo; Seiji Shioda
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, Oct. 2012, [Reviewed]
Neonatal brain function was investigated in a prenatal BrdU-induced developmental disorder model, which has been reported to exhibit behavioral abnormalities such as locomotor hyperactivity, impaired learning and memory, and lower anxiety in offspring. After 1h home cage deprivation we observed an increase in the number of c-Fos (neuronal activity marker) immunoreactive cells in several brain regions of the olfactory and stress-related areas in normal neonates at 11 days. Next, pregnant rats were exposed to 50mg/kg of BrdU from gestation days 9-15, and their offspring at 11 days were home-cage deprived. Compared to vehicle control, the number of c-Fos immunoreactive cells in BrdU group was found to be decreased in the piriform cortex and locus coeruleus, which are known to play an important role in neonatal learning and memory. We also analyzed Pearson product-moment correlation coefficient of the number of c-Fos immunoreactive cells, focusing on the piriform cortex and locus coeruleus versus numerous other brain areas (11 areas including amygdala). Numerous significant correlations were observed in the vehicle control group, however, correlations of the locus coeruleus disappeared in the BrdU group. By observing c-Fos immunoreactivity after home cage deprivation our study uncovers abnormal brain functions as early as postnatal day 11 in this disorder model. Based on these results, we propose a new histological approach for functional characterization of developmental disorder models. - Current problems of in vivo developmental neurotoxicity tests and a new in vivo approach focusing on each step of the developing central nervous system.
Makiko Kuwagata
Congenital anomalies, Sep. 2012, [Reviewed]
Developmental neurotoxicity (DNT) tests usually focus on postnatal indicators, such as behavior and neuropathology, for the detection of chemically induced neurodevelopmental defects in the central nervous system (CNS). However, low reliability, especially low reproducibility, of behavioral results often causes concern among scientists and the scientific community in general. Guidance of neurohistopathological examination in the DNT guideline also has some shortcomings, especially relating to the methodological aspects. Ongoing international trends in DNT tests have shifted from the use of original in vivo animal (mammalian) studies to in vitro experiments using cell cultures and/or non-mammalian species, such as fish. In vitro systems might initially be useful to screen test chemicals for their DNT potential. Although in vitro systems are employed as alternative approaches for DNT studies, the use of in vivo studies based on animal models remains an important factor when data are to be extrapolated to the human case. In this review, a new in vivo approach that focuses on histopathological observation of each developmental step of the CNS, such as proliferation of neural stem cells, migration of immature neurons, and formation of neural networks, using fetal and neonatal brains after chemical exposure is introduced, and some queries and arguments for current DNT experimental guidelines are discussed. - Usefulness of combined in vivo skin comet assay and in vivo skin micronucleus test.
Tomoyasu Toyoizumi; Ryo Ohta; Kumiko Kawakami; Yuzuki Nakagawa; Yoshiyuki Tazura; Makiko Kuwagata; Satoshi Noguchi; Hajime Sui; Kohji Yamakage
Mutation research, 18 Mar. 2012, [Reviewed]
We have already found that the in vivo skin comet assay is useful for the evaluation of primary DNA damage induced by genotoxic chemicals in epidermal skin cells. The aim of the present study was to evaluate the sensitivity and specificity of the combined in vivo skin comet assay and in vivo skin micronucleus (MN) test using the same animal to explore the usefulness of the new test method. The combined alkaline comet assay and MN test was carried out with three chemicals: 4-nitroquinoline-1-oxide (4NQO), N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) and benzo[a]pyrene (B[a]P). In the first experiment, we compared DNA- and chromosome-damaging effects of 3 [72, 24 and 3 hours (h) before sacrifice] and 4 applications (72, 48, 24 and 3h before sacrifice) of 4NQO, which induces dermal irritancy. The animals were euthanized and their skin was sampled for the combination test. As a result, the 4-application method was able to detect both DNA- and chromosome-damaging potential with a lower concentration; therefore, in the second experiment, MNNG and B[a]P were topically applied four times, respectively. The animals were euthanized, and then their skins were sampled for combination tests. In the alkaline comet assay, significant differences in the percent of DNA (%DNA) in the tail were observed in epidermal skin cells treated with MNNG and B[a]P. In the MN test, an increased frequency of MN cells (%MN) cells was observed by treatment with MNNG; however, there were no significant increases. In contrast, significant differences in %MN were observed by treatment with B[a]P. From these results, we conclude that the combined in vivo skin comet assay and in vivo MN test was useful because it can detect different genotoxicity with the same sampling time and reduce the number of animals used. - Use of the in vivo skin comet assay to evaluate the DNA-damaging potential of chemicals applied to the skin.
Tomoyasu Toyoizumi; Ryo Ohta; Yuzuki Nakagawa; Yoshiyuki Tazura; Makiko Kuwagata; Satoshi Noguchi; Kohji Yamakage
Mutation research, 24 Dec. 2011, [Reviewed]
The aim of the present study was to evaluate both sensitivity and specificity of an in vivo skin comet assay using chemically treated, hairless mouse dorsal skin as a model. N-methyl-N'-nitro-N-nitrosoguanidine (MNNG, 0.0125-0.2%), 4-nitroquinoline-1-oxide (4NQO, 0.01-0.25%), mitomycin C (MMC, 0.0125-0.05%), benzo[a]pyrene (B[a]P, 0.25-2%), and 7,12-dimethylbenz[a]anthracene (DMBA, 0.25-1%) were each applied once to the dorsal skin of hairless male mice; after 3h, epidermal skin cells were isolated, and the alkaline comet assay was performed. The assay was performed after 24h for only the B[a]P and DMBA. Furthermore, B[a]P and DMBA were evaluated by alkaline comet assay using liver cells after both 3 and 24h. The mean percent of DNA (%DNA) in tail in the 0.05-0.2% MNNG and 0.1-0.25% 4NQO treatment groups was markedly higher than in the control group at 3h post-application. Although the mean %DNA values in the tail in the B[a]P and DMBA groups were the same as the controls at 3h post-application, the 2% B[a]P and 1% DMBA groups showed significantly higher values versus controls 24h after application. No significant increases in the mean %DNA in the tail were observed in the MMC group. No clear increases in %DNA in the tail were observed in the B[a]P and DMBA groups at 3 or 24h after application in the liver. These results suggest that the in vivo skin comet assay is able to accurately identify DNA-damaging potential with a skin-specific response and is a useful method to detect the DNA-damaging potential of genotoxic chemicals on the skin. - Hyperactivity induced by prenatal BrdU exposure across several experimental conditions.
Makiko Kuwagata; Tetsuo Ogawa; Katsumasa Muneoka; Seiji Shioda
Congenital anomalies, Dec. 2011, [Reviewed]
Behavioral results are sometimes not reproducible even in the positive controls of developmental neurotoxicity (DNT) tests. Effects of several factors on the results should be considered. In the present paper, we examined the effects of strain-, gender-, and test-condition differences on BrdU-induced hyperactivity. The results showed that BrdU-induced hyperactivity was reproducible in two rat strains (SD and F344 rats), rodent species (rat and mouse), and both sexes. When the level of background sound in a test room was increased, the hyperactivity was persistent, resulting in no effect of background sound on BrdU-induced hyperactivity. Thus, we have demonstrated that the BrdU-animal model is a useful positive control via prenatal exposure to validate the entire DNT test process. - Effect of Nucleoprotein Diet on Expression of Gene Candidates for Developmental Origins of Health and Disease (DOHaD)
Tetsuo Ogawa; Randeep Rakwal; Junko Shibato; Chika Sawa; Tomomi Saito; Aya Murayama; Makiko Kuwagata; Haruaki Kageyama; Masaji Matsunaga; Kouji Usumi; Seiji Shioda
JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE, Sep. 2011, [Reviewed] - Seeking gene candidates responsible for developmental origins of health and disease.
Tetsuo Ogawa; Randeep Rakwal; Junko Shibato; Chika Sawa; Tomomi Saito; Aya Murayama; Makiko Kuwagata; Haruaki Kageyama; Michiko Yagi; Kazue Satoh; Seiji Shioda
Congenital anomalies, Sep. 2011, [Reviewed]
Human epidemiological evidence has led scientists to theorize that undernutrition during gestation is an important early origin of adult diseases. Animal models have successfully demonstrated that maternal diet could contribute to some adult diseases. Undernutrition is perceived harmful in pregnant women, whereas calorie restriction is a strategy proven to extend healthy and maximum lifespan in adult. This diagrammatically opposite effect of nutritional condition might provide us with hints to search for genes underlying health conditions. Here, we have initiated a study examining the effect of undernutrition on maternal and fetal livers, utilizing high-throughput DNA microarray analysis for screening genome-wide changes in their transcriptomes. Briefly, pregnant mice were exposed to food deprivation (FD) on gestation day (GD) 17, and cesarean section was performed on GD18. Control mice were supplied with chow ad libitum until sacrifice. Total RNA extracted from mother and fetal livers for each control and treatment (FD) was analyzed with an Agilent mouse whole genome DNA chip. A total of 3058 and 3126 up- (>1.5-fold) and down- (<0.75-fold) regulated genes, and 1475 and 1225 up- (>1.5-fold) and down- (<0.75-fold) regulated genes showed differential expression at the mRNA level, in the maternal and fetal livers, respectively. Interestingly, 103 genes up-regulated in the mother were down-regulated in the fetus, whereas 108 down-regulated maternal genes were up-regulated in the fetus; these 211 genes are potential candidates related to longevity or health. The role of some of these genes, in context of the proposed mechanisms for developmental origins of health and disease is discussed. - Distribution of the longevity gene product, SIRT1, in developing mouse organs.
Tetsuo Ogawa; Chizu Wakai; Tomomi Saito; Aya Murayama; Yuuichi Mimura; Sachiko Youfu; Tomoya Nakamachi; Makiko Kuwagata; Kazue Satoh; Seiji Shioda
Congenital anomalies, Jun. 2011, [Reviewed]
A longevity gene product, Sir2 (silent information regulator 2) is a NAD-dependent histone deacetylase involved in longevity in yeasts, worms and flies. The mammalian homolog of Sir2, SIRT1(sirtuin 1), has been shown to play important roles related to anti-aging effects (regulating apoptosis, stress tolerance, insulin resistance, and fat metabolism). Recently, SIRT1 expression has been demonstrated to occur at as early as embryonic day 10.5 in mice. SIRT1 during developing period may be involved in the mechanism of developmental origins of adult diseases, such as diabetes and cardiovascular disease. To investigate the contribution of SIRT1, it is important to reveal the distribution of this protein during development. In the present study, we demonstrated the distribution of immunoreactivity of SIRT1 in mouse organs during prenatal and neonatal development by staining a wide variety of serial sections. The SIRT1 immunoreactivity was strongly observed in the neuroepithelial layer, dorsal root ganglion, trigeminal ganglion, eyes, roots of whiskers, and internal organs, including the testis, liver, heart, kidney, and lung during the fetal period. Neurons which had finished migrating still showed relatively strong immunoreactivity. The immunoreactivity was completely absorbed by the blocking peptide in an absorption test. During the postnatal period, the immunoreactivities in most of these organs, except the heart and testis weakened, with the liver most dramatically affected. As SIRT1 expression was demonstrated in a wide variety of developing organs, further study to investigate prenatal factors which affect SIRT1 expression and its activity is important. - Effects of the genotoxic agent 5-bromo-2'-deoxyuridine with or without pre-pubertal gonadectomy on brain monoamines and their metabolites in female rats.
Makiko Kuwagata; Katsumasa Muneoka; Tetsuo Ogawa; Seiji Shioda
Brain research bulletin, 30 May 2011, [Reviewed]
A nucleotide analog 5-bromo-2'-deoxyuridine (BrdU) is a genotoxic compound. Previous studies have demonstrated that prenatal treatment of rodents with BrdU affects the development of cortical neurons, reduces dopamine levels, and elevates serotonin (5-HT) levels in the striatum in adult male offspring from BrdU-treated dams. Moreover, prenatal BrdU-treated rats show locomotor hyperactivity in both males and females. This study investigated sexual dimorphism in the effect of prenatal BrdU on monoamine metabolism. Sprague-Dawley rats were treated with BrdU on gestational days 9-15 (50mg/kg, i.p.) and monoamine metabolism was examined in female rats at 10 weeks of age. The influence of pre-pubertal gonadectomy on the effects of BrdU was also investigated. BrdU-treated females showed elevations of dopamine and 5-HT levels in the striatum; reductions in dopamine, dihydroxyphenylacetic acid, or homovanillic acid (HVA) in the hypothalamus or the midbrain; and elevated HVA and 5-HT in the hippocampus. Pre-pubertal gonadectomy had a suppressive effect on striatal dopamine levels in prenatal BrdU-treated females. The present data indicate sexual dimorphic effects of prenatal BrdU-treatment in striatal dopamine metabolism but not in serotonergic metabolism and suggest a contribution of the increasing gonadal hormones that accompany puberty to this sex difference. - Sex-specific effects of early neonatal progesterone treatment on dopamine and serotonin metabolism in rat striatum and frontal cortex
Katsumasa Muneoka; Makiko Kuwagata; Tetsuo Ogawa; Seiji Shioda
Life Sciences, 18 Dec. 2010, [Reviewed] - Biphasic effects of neonatal allopregnanolone on striatal dopamine metabolism
Katsumasa Muneoka; Makiko Kuwagata; Yukihiko Shirayama; Tetsuo Ogawa; Seiji Shioda
NeuroReport, 17 Jun. 2009, [Reviewed] - Observation of fetal brain in a rat valproate-induced autism model: a developmental neurotoxicity study.
Makiko Kuwagata; Tetsuo Ogawa; Seiji Shioda; Tomoko Nagata
International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, Jun. 2009, [Reviewed]
Prenatal exposure to chemicals is well known to induce developmental abnormalities in the central nervous system of children. Developmental neurotoxicity (DNT) tests are important to identify neurotoxic agents and prevent neurodevelopmental disorders. We have investigated DNT, focusing on the fetal brain shortly after chemical exposure. To demonstrate a usefulness of a study focusing on the fetal brain in DNT tests, we assessed the fetal brain in a rat valproate-induced autism model. Rats were treated with sodium valproate (VPA, 800 mg/kg) orally on gestational day (GD) 9 or 11 (VPA9 or VPA11), and the fetal brains were examined on GD16 using immunohistochemistry for serotonin (5-HT), tyrosine hydroxylase (TH), and TuJ1 (neuron specific class III beta-tubulin). Hypoplasia of the cortical plate was induced in both VPA9 and VPA11 groups. Abnormal migration of TH-positive and 5-HT neurons, possibly due to the appearance of an abnormally running nerve tract in the pons, was observed only in the VPA11 group. In addition, when we compared the incidence of these abnormalities between pregnant rats mated in our own animal facility (in-house group), and rats purchased pregnant (supplier group), the supplier group was much more sensitive, especially to the pons abnormality. Shipping stress may affect the reproducibility of VPA-induced DNT. The present results demonstrate that examination of the GD16 fetal brain was useful for detecting and characterizing abnormal development of the brain after VPA exposure. Further discussion was made with reference to the findings in children with autism. - Characteristic behavioral anomalies in rats prenatally exposed to 5-bromo-2′-deoxyuridine
Kensuke Orito; Akihiko Morishima; Tetsuo Ogawa; Katsumasa Muneoka; Makiko Kuwagata; Jiro Takata; Kenichi Mishima; Michihiro Fujiwara
International Journal of Developmental Neuroscience, Feb. 2009, [Reviewed] - Valproate-induced developmental neurotoxicity is affected by maternal conditions including shipping stress and environmental change during early pregnancy.
Tetsuo Ogawa; Makiko Kuwagata; Yasunori Hori; Seiji Shioda
Toxicology letters, 01 Nov. 2007, [Reviewed]
Prenatal stress is known to affect the development of the brain, and exaggerate the developmental toxicity of chemicals. Many studies of developmental neurotoxicity (DNT) use pregnant rodents mated at the supplier, which consequently suffer from the stress of shipping and of environmental changes. Here, we demonstrated differences in the developmental neurotoxicity induced by valproate (VPA) between pregnant rats mated at our own animal facility (in-house group) and rats purchased pregnant (supplier group). Rats were treated with VPA (800mg/kg) orally on gestation day (GD) 9 or 11 (VPAE9 or VPAE11), and the fetal brain was examined at embryonic day 14 using immunohistochemistry for TuJ1 (a marker for immature neurons). The size of the fetal brain was also measured. The treatment decreased fetal live viability and fetal body weight only in the supplier group. VPA treatment on either day impaired the development of TuJ1-positive neurons in the cerebral cortex. The size of the forebrain was also affected by VPA. The supplier group was much more sensitive to these toxic effects. Therefore, difference in mating place (one's own animal facility or supplier) takes part in reproducibility of valproate-induced DNT. - The evaluation of early embryonic neurogenesis after exposure to the genotoxic agent 5-bromo-2'-deoxyuridine in mice.
Makiko Kuwagata; Tetsuo Ogawa; Tomoko Nagata; Seiji Shioda
Neurotoxicology, Jul. 2007, [Reviewed]
Developmental neurotoxicity (DNT) is an important issue in children's health. Neurogenesis occurs throughout the early fetal to the postnatal period. The proliferation of embryonic stem cells can be a target for toxicants, especially genotoxic compounds. 5-Bromo-2'-deoxyuridine (BrdU), a thymidine analogue, has been used as a marker for proliferating cells. However, we reported that prenatal BrdU exposure induced behavioral abnormalities such as hyperactivity in rat and mouse offspring. In this study, to further clarify the toxic effect of BrdU on the early neurogenesis and to examine the usefulness of the evaluation of this process in DNT, C57BL/6 mice were exposed to 100 mg/kg of BrdU once on gestational day (GD) 9 or 11, and serial sections from a wide variety of areas of the embryonic brains 24 h after the exposure were examined. BrdU exposure on GD11 induced cell death in some specific areas, such as the neocortex and striatum, but not in the substantia nigra, raphe and pons, even though BrdU was incorporated into those cells. BrdU decreased the number of cells positive for phosphorylated histone 3 (phospho-histone 3), a marker for proliferating cells at metaphase of mitosis, in the cortex, mammillary body and cerebellum, suggesting that BrdU affected the proliferation of neural stem cells. Exposure on GD9 did not induce cell death in the fetal brain. These results indicate that BrdU actually impaired the early neurogenesis, supporting the postnatal results, and demonstrated that embryonic neurogenesis has heterogeneous sensitivity to the genotoxic agents BrdU that differs according to the area and developmental stage. The evaluation of events in early neurogenesis such as the proliferation of neural stem cells shortly after chemical exposure will be one of the valuable endpoints for studying postnatal neurodevelopmental disorders. - Dopamine transporter density and behavioral response to methylphenidate in a hyperlocomotor rat model
Katsumasa Muneoka; Makiko Kuwagata; Masaaki Iwata; Yukihiko Shirayama; Tetsuo Ogawa; Morikuni Takigawa
Congenital Anomalies, Sep. 2006, [Reviewed] - S-100B expression in neonatal rat cortical "barrels" and thalamic "barreloids"
Katsumasa T. Muneoka; Hisayuki Funahashi; Tetsuo Ogawa; Makiko Kuwagata; Patricia M. Whitaker-Azmitia; Seiji Shioda
BREATHING, FEEDING AND NEUROPROTECTION, 2006, [Reviewed] - Neuropathological examination of fetal rat brain in the 5-bromo-2′-deoxyuridine-induced neurodevelopmental disorder model
Tetsuo Ogawa; Makiko Kuwagata; Katsumasa T. Muneoka; Seiji Shioda
Congenital Anomalies, Mar. 2005, [Reviewed] - Locomotor hyperactivity following prenatal exposure to 5-bromo-2′- deoxyuridine: Neurochemical and behavioral evidence of dopaminergic and serotonergic alterations
Makiko Kuwagata; Katsumasa T. Muneoka; Tetsuo Ogawa; Morikuni Takigawa; Tetsuji Nagao
Toxicology Letters, 30 Aug. 2004, [Reviewed] - Intrauterine position and postnatal growth in Sprague-Dawley rats and ICR mice
T Nagao; K Wada; M Kuwagata; M Nakagomi; C Watanabe; S Yoshimura; Y Saito; K Usumi; J Kanno
REPRODUCTIVE TOXICOLOGY, Jan. 2004, [Reviewed]
MISC
- Diverse on-target mutations in the genome-edited mice and their transmission to the next generation
Toshime Igarashi; Yukuto Yasuhiko; Ryuichi Ono; Yu Takahashi; Makiko Kuwagata; Satoshi Kitajima
Experimental Animals, 2024
Japanese Association for Laboratory Animal Science - Comparative study of regulatory systems in other countries to ensure the safety of “new foods”
Toshime Igarashi; Mari Matsumura; Izumi Ogawa; Chiori Yakawa; Takahiko Hayakawa; Miyoko Ochi; Hirokatsu Saito; Makiko Kuwagata; Satoshi Kitajima
Journal of Toxicological Sciences, 2022 - Uterotrophic bioassay of 4,4'-(1,3-dimethylbutylidene) diphenol, a bisphenol analog, using ovariectomized mice by subcutaneous and oral administration
Toshime Igarashi, Sakiko Fujii, Mariko Tsurumoto, Yuji Taquahashi, Satoshi Kitajima, Makiko Kuwagata
Journal of Toxicological Sciences, 2022 - 25th anniversary of the Berlin workshop on developmental toxicology: DevTox database update, challenges in risk assessment of developmental neurotoxicity and alternative methodologies in bone development and growth
Philip Marx-Stoelting; Marize de L.M. Solano; Hiroaki Aoyama; Ralf H. Adams; Anna Bal-Price; Jochen Buschmann; Ibrahim Chahoud; Ruth Clark; Tian Fang; Michio Fujiwara; Michael Gelinsky; Konstanze Grote; Masao Horimoto; Susanne Hougaard Bennekou; Rupert Kellner; Makiko Kuwagata; Marcel Leist; Annemarie Lang; Weihua Li; Alberto Mantovani; Susan L. Makris; Francisco Paumgartten; Monique Perron; Magdalini Sachana; Anne Schmitt; Steffen Schneider; Gilbert Schönfelder; Frank Schulze; Kohei Shiota; Roland Solecki
Reproductive Toxicology, 01 Mar. 2021
Elsevier Inc. - Germline-transmission in the knock-in mice of N0 generation with diverse and unintended on-target mutations induced by CRISPR/Cas9-mediated genome editing.
Toshime Igarashi; Yukuto Yasuhiko; Ryuichi Ono; Erika Tachihara; Miki Uchiyama; Atsuya Takagi; Yu Takahashi; Makiko Kuwagata; Satoshi Kitajima
2021 - CRISPR/Cas9-mediated genome editing of mouse zygotes induces diverse on-target unintentional mutations.
Toshime Igarashi; Yukuto Yasuhiko; Ryuichi Ono; Erika Tachihara; Yu Takahashi; Makiko Kuwagata; Satoshi Kitajima
Journal of Toxicological Sciences, 2020 - 生活習慣病胎児期起源説に基づく生活習慣病関連遺伝子の網羅的検索
小川 哲郎; ラクワル・ランディープ; 柴藤 淳子; 澤 智華; 齋藤 智美; 村山 綾; 桑形 麻樹子; 影山 晴秋; 佐藤 和恵; 塩田 清二
日本抗加齢医学会総会プログラム・抄録集, Apr. 2011
(一社)日本抗加齢医学会 - P-035 Availability of combined-skin comet assay and skin micronucleus test using hairless mice(Poster Presentation)
Toyoizumi Tomoyasu; Ohta Ryo; Kawakami Kumiko; Nakagawa Yuzuki; Tazura Yoshiyuki; Kuwagata Makiko; Noguchi Satoshi; Sui Hajime; Yamakage Kohji
2011 - ラット胎生期バルプロ酸曝露による自閉症モデルの胎児および新生児脳の観察
桑形 麻樹子; 小川 哲郎; 影山 晴秋; 永田 伴子; 塩田 清二
解剖学雑誌, Mar. 2010
(一社)日本解剖学会 - Behavioral and reproductive function of rat male offspring treated prenatally with 5-bromo-2'-deoxyuridine
KUWAGATA M
Reprod Toxicol, 1998
Lectures, oral presentations, etc.
- Research on the mechanism of thoracolumbar supernumerary rib development after birth using CT scanning
Makiko Kuwagata
14 Sep. 2018, [Invited]
Research Themes
- Elucidation of the onset mechanism of osteoporosis and osteoarthritis caused by stress on mesenchymal stem cells
Grant-in-Aid for Scientific Research (C)
01 Apr. 2017 - 31 Mar. 2020
Surgery to remove the ovaries was performed on female offspring undernutrition in the rat dams during early pregnancy. Osteoporosis and osteoarthritis could not be confirmed in the undernutrition menopausal model rat. However, it led to clear that they fell into severe obesity. In addition, it was suggested that early embryonic undernutrition stress causes non-alcoholic fatty liver disease. - Multi-omics approach unraveling neonatal mouse brain for DOHaD
Grant-in-Aid for Scientific Research (C)
University of Tsukuba
01 Apr. 2017 - 31 Mar. 2020
The DOHaD theory that the nutritional environment in the fetal and neonatal period is behind the risk of developing adult diseases has been advocated. Recently, it has been pointed out that it is also associated with mental disorders such as depression. Data of the neonatal brain and fetal brain of undernourished mice was performed in order to elucidate the predisposition mechanism of psychiatric disorders based on the DOHaD theory (Project C: Elucidation of the molecular basis of adult disease development focusing on fetal tissues as a result of a comparative examination in 2011-2013), and an increase in haptoglobin gene expression was confirmed. Haptoglobin is also a marker for inflammatory diseases, and many other factors involved in the acute phase reaction proteins and myelin regeneration were detected. It was suggested that the malnutrition environment may increase the risk of neurological diseases by causing inflammation in the fetal/neonatal brain. - Mechanism of vulnerability formation by nutritional environment change at developmental stage.
Grant-in-Aid for Scientific Research (C)
Showa University
01 Apr. 2015 - 31 Mar. 2019
We have investigated candidate genes which are associated with increased risk of adult diseases by analyzing developing tissues from the C57BL/6J mouse model of developmental origins of health and disease (DOHaD). We focused on experimental evidence that the effect of undernutrition on adult offspring is opposite between the fetal and neonatal periods. We selected 21 candidate genes which were expressed opposite between prenatal and neonatal undernutrition. After 7-days neonatal 50% food restriction in dam, offspring kept until 11-weeks of age. At 11-weeks of age, LPS (TLR4 inducer) was administered to offspring and expression of 21 candidate genes were examined. One of 21 genes such as OATP family transporter (Slco2b1) were affected, and development of spleen and thymus altered after neonatal undernutrition. Adult LPS treatment changed 4 genes such as Lrtm1, Mrap, Il1b, and Slco2b1 between neonatal FR offspring and control offspring. These four genes may be candidate genes for DOHaD. - 発生毒性試験における胎児形態異常に関するデータ収集と骨格変異の毒性学的意義に関する研究:フルシトシン誘発性過剰肋骨の発現機序からの考察
Nov. 2016 - Mar. 2019 - later
Grant-in-Aid for Scientific Research (C)
Showa University
01 Apr. 2012 - 31 Mar. 2015
Although undernutrition during gestation is harmful for fetuses, calorie restriction is a strategy proven to extend healthy and maximum life span after birth. By focusing our attention on genes whose expression oppositely regulated between under- or high-nutrition during neonatal period, we selected candidate genes responsible for DOHaD. The results of microarray in C57BL mouse pup’s liver exposed to neonatal under- (50% food restriction) and high-nutrition (60% high fat food) demonstrated that innate immune system (Fos、Il1b、Rgs1、Ppp1r3g、Hamp、Igll1) was activated shortly after exposure. At weaning, expression of Aldhla 7 was decreased resulting of low resolution of acetaldehyde regardless of the nutritional conditions. By histopathological examination, abnormal development of immune tissues such as thymus and spleen was detected. - Histone modification in a rat fetal brain an neuronal network formation in a rat neonate after prenatal valproic acid treatment.
Grant-in-Aid for Scientific Research (C)
Showa University
2009 - 2011
Clinical reports revealed that VPA exposure during early pregnancy increases the risk of a child having an autistic disorder. In this study, focusing on VPA pharmacological action, inhibition of histone deacetylase, the relationship between histone modification and morphological changes in the rat fetal brain after VPA treatment was examined. Disruption of neuronal migration in the cortex was detected in SD, F344 as well as Wistar Kyoto(WK) rat fetus at the gestational day(GD) 16 after VPA treatment at GD11. However, abnormal neural running tract in the midbrain was observed in SD rat fetal brain, but not in F344 or WK rat fetal brain, indicating that "some" morphological changes in the fetal brain are partly due to genetic factors. In the functional observation of neonates on postnatal day 11, an abnormal brain function, such as an increase in fear response, was identified on analyzing the distribution of c-Fos immunoreactive cells after maternal derivation in neonate treated prenatally with VPA. The study could not go to schedule in order to different sensitivity for VPA among rat strains. Therefore, effects of histone modification by VPA on morphological changes in a rat fetal brain have not revealed in this study period. - A new approach for the detection of developmental neurotoxicity induced by prenatal chemical exposure and an analysis of the critical period for the induction of neurodevelopmental disorders.
Grant-in-Aid for Scientific Research (C)
Showa University
2005 - 2006
In this research, using two animal models for neurodevelopmental disorders (ND) such as hyperactivity (an easy model to detect some behavioral changes in a behavioral test) and autism (difficult model), the usefulness of histopathological observation of the fetal rodent brain after chemical exposure, and the analysis of the critical period for induction of ND were evaluated. The relationship between findings obtained from fetal brain and postnatal behavioral abnormality was also investigated.
We already reported that 5-bromo-2'-deoxyuridine (BrdU) induced hyperactivity in offspring when BrdU was administered to rats on gestational days (GD) 9 to 15. In this study, a treatment period was divided before (GD9-10) and after the closure of neural tube (GD11-13, GD14-15). The critical period of hyperactivity induced by prenatal BrdU exposure was estimated to begin after closure of the neural tube and continued for a relatively long period. On observation of GD16 fetal brain, dysgenesis of the cortical plate (CP) was observed in the GD11-13, GD14-15 and GD9-15 (positive control)-treated groups. The findings in GD16 fetal brain (abnormal CP) reflected the grade of hyperactivity in the offspring.
As a proposed rat model of autism, valproic acid (VPA, 800mg/kg) was administered to rats on GD9 or GD11 (before and after closure of the neural tube). GD9 treatment increased fetal mortality. Dysgenesis of CP was observed in both GD9 and GD11 treatments. Retardation of development of pons was detected in GD11-treated group.
In conclusions, examination of fetal brains shortly after chemical exposure is a good new endpoint to support postnatal observation in developmental neurotoxicity (DNT) tests. The concept of critical period of ND should be important to improve the sensitivity and reproducibility of a DNT test.